DexCom
DXCM
84.30
+0.91
+1.09%
DexCom
US · DXCM
#635 by market cap
Listed 2005
84.30
+0.91
+1.09%
Live - 5344 symbols - heartbeat 478s ago
· 2026-10-08 07:40
Pre-market
84.24
-0.07%
After-hours
84.30
0.00%
Overnight
84.24
-0.07%
- Market cap
- 31.81B
- P/E (TTM)i
- 33.32
- P/Bi
- 12.13
- EPSi
- 2.09
- Div yieldi
- 0.00%
- 52W posi
- 78%
Reader sentiment
Are you bullish or bearish on DXCM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.42, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.60% YoY
Margins
- Gross margin
- 60.10%
- Operating margin
- 19.56%
- Net margin
- 17.94%
Key ratios & quality
- Enterprise valuei
- 31.08B
- PEG ratioi
- 0.96
- Altman Z-Scorei
- 7.42
PEG uses trailing P/E against the 3-year net income growth rate (34.83%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.03B | 1.48B | 1.93B | 2.45B | 2.91B | 3.62B | 4.03B | 4.66B |
| Gross profit | 663.90M | 931.50M | 1.28B | 1.68B | 1.88B | 2.29B | 2.44B | 2.80B |
| Selling & admin expenses | 432.80M | 515.70M | 620.70M | 810.50M | 1.01B | 1.19B | 1.29B | 1.29B |
| Research & development | 417.40M | 273.50M | 359.90M | 604.20M | 484.20M | 505.80M | 552.40M | 599.10M |
| Operating profit | -186.30M | 142.30M | 299.50M | 265.80M | 391.20M | 597.70M | 600.00M | 911.80M |
| Pretax profit | -126.50M | 104.20M | 225.00M | 256.80M | 390.80M | 710.40M | 709.00M | 1.09B |
| Tax | 600.00K | 3.10M | -268.60M | 39.90M | 49.60M | 168.90M | 132.80M | 252.10M |
| Net profit | -127.10M | 101.10M | 493.60M | 216.90M | 341.20M | 541.50M | 576.20M | 836.30M |
| Basic EPS | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | -0.36 | 0.28 | 1.27 | 0.53 | 0.82 | 1.30 | 1.42 | 2.09 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.04B | 1.16B | 1.21B | 1.26B | 1.19B | 1.31B |
| Gross profit | 589.00M | 688.80M | 731.40M | 792.70M | 750.30M | 830.00M |
| Selling & admin expenses | 310.10M | 328.00M | 331.40M | 321.50M | 349.70M | 358.70M |
| Research & development | 145.20M | 148.20M | 157.50M | 148.20M | 145.30M | 153.00M |
| Operating profit | 133.70M | 212.60M | 242.50M | 323.00M | 255.30M | 318.30M |
| Pretax profit | 154.30M | 241.10M | 352.30M | 340.70M | 269.50M | 317.50M |
| Tax | 48.90M | 61.30M | 68.50M | 73.40M | 70.00M | 68.40M |
| Net profit | 105.40M | 179.80M | 283.80M | 267.30M | 199.50M | 249.10M |
| Basic EPS | 0 | 0 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.27 | 0.45 | 0.70 | 0.68 | 0.51 | 0.64 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.70B | 1.97B | 3.42B | 3.68B | 3.67B | 4.43B | 4.30B | 4.03B |
| Cash & ST investments | 1.39B | 1.53B | 2.71B | 2.73B | 2.46B | 2.72B | 2.58B | 2.00B |
| Inventory | 70.70M | 119.80M | 234.70M | 357.30M | 306.70M | 559.60M | 542.60M | 629.10M |
| Total assets | 1.92B | 2.40B | 4.29B | 4.93B | 5.39B | 6.26B | 6.48B | 6.34B |
| Total current liabilities | 222.40M | 360.20M | 614.10M | 720.80M | 1.84B | 1.56B | 2.93B | 2.14B |
| Short-term debt | -- | 13.60M | 16.50M | 20.50M | 793.10M | 21.10M | 1.23B | 21.60M |
| Long-term debt | 1.01B | 1.06B | 1.67B | 1.98B | 1.20B | 2.43B | 1.24B | 1.24B |
| Total liabilities | 1,252,700,000.00 | 1,512,400,000.00 | 2,464,000,000.00 | 2,891,200,000.00 | 3,259,900,000.00 | 4,195,900,000.00 | 4,381,900,000.00 | 3,593,900,000.00 |
| Total equity | 663.30M | 882.60M | 1.83B | 2.04B | 2.13B | 2.07B | 2.10B | 2.75B |
| Retained earnings | -798.90M | -695.70M | -202.10M | 138.70M | 479.90M | 1.02B | 1.60B | 2.43B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.55B | 5.03B | 5.22B | 4.03B | 4.33B | 4.09B |
| Cash & ST investments | 2.70B | 2.93B | 3.32B | 2.00B | 2.42B | 1.95B |
| Inventory | 538.20M | 570.70M | 604.10M | 629.10M | 693.60M | 726.40M |
| Total assets | 6.75B | 7.33B | 7.50B | 6.34B | 6.63B | 6.46B |
| Total current liabilities | 3.04B | 3.31B | 3.34B | 2.14B | 2.22B | 2.36B |
| Short-term debt | 1.23B | 1.23B | 1.23B | 21.60M | 20.50M | 20.70M |
| Long-term debt | 1.24B | 1.24B | 1.24B | 1.24B | 1.24B | 1.24B |
| Total liabilities | 4,485,100,000.00 | 4,753,900,000.00 | 4,773,900,000.00 | 3,593,900,000.00 | 3,676,400,000.00 | 3,833,900,000.00 |
| Total equity | 2.27B | 2.57B | 2.73B | 2.75B | 2.96B | 2.62B |
| Retained earnings | 1.70B | 1.88B | 2.17B | 2.43B | 2.63B | 2.88B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 123.20M | 314.50M | 475.60M | 442.50M | 669.50M | 748.50M | 989.50M | 1.44B |
| Depreciation & amortization | 29.10M | 48.70M | 67.10M | 102.00M | 155.90M | 186.00M | 217.70M | 251.80M |
| Free cash flow | 56.10M | 134.50M | 276.60M | 53.30M | 304.70M | 511.90M | 630.70M | 1.08B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -89.20M | 11.90M | 15.30M | 20.30M | -535.20M | -662.10M | -721.80M | -471.90M |
| Ending cash balance | 1.14B | 446.40M | 818.20M | 1.05B | 643.30M | 567.50M | 607.30M | 919.10M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 183.80M | 303.00M | 659.90M | 294.00M | 525.60M | 269.20M |
| Depreciation & amortization | 60.00M | 63.00M | 63.60M | 65.20M | 67.10M | 68.20M |
| Free cash flow | 96.80M | 208.90M | 579.40M | 192.10M | 449.00M | 184.50M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 14.20M | 0 | -173.30M | -312.80M | 12.70M | -603.60M |
| Ending cash balance | 906.10M | 1.16B | 1.84B | 919.10M | 1.12B | 1.11B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -23.48 | 13.08 | 36.44 | 7.59 | 15.57 | 25.78 | 27.63 | 34.50 |
| ROA %i | -9.01 | 4.69 | 14.77 | 3.38 | 6.65 | 9.29 | 9.04 | 13.04 |
| ROIC %i | -9.22 | 7.17 | 19.05 | 6.08 | 8.50 | 10.16 | 10.32 | 17.31 |
| 5-year avg ROE %i | -23.12 | -16.51 | -2.84 | 4.60 | 10.72 | 20.57 | 23.48 | 23.09 |
| EBIT margin %i | -10.06 | 11.15 | 16.07 | 11.27 | 14.07 | 20.17 | 18.05 | 23.74 |
| FCF / sales %i | 5.44 | 9.11 | 14.36 | 2.18 | 10.47 | 14.13 | 15.64 | 23.11 |
| Current ratioi | 7.64 | 5.47 | 5.58 | 5.11 | 1.99 | 2.84 | 1.47 | 1.88 |
| Quick ratioi | 7.25 | 5.05 | 5.11 | 4.51 | 1.74 | 2.39 | 1.24 | 1.53 |
| Debt / assetsi | 53.11 | 48.44 | 42.87 | 43.74 | 39.78 | 41.41 | 39.90 | 21.92 |
| LT debt / equityi | 153.41 | 129.90 | 99.81 | 104.67 | 63.42 | 124.38 | 64.71 | 49.82 |
| Interest coveragei | -4.57 | 2.73 | 3.66 | 2.70 | 22.01 | 36.00 | 38.32 | 60.48 |
| Revenue CAGR (3Y) %i | 36.91 | 37.06 | 38.93 | 33.39 | 25.39 | 23.42 | 18.10 | 17.01 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | 50.00 | 3.14 | 38.50 | 34.83 |
| FCF CAGR (3Y) %i | 52.88 | 545.53 | 119.93 | -1.69 | 31.34 | 22.78 | 127.88 | 52.34 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 23.72 | 22.83 | 30.63 | 34.50 | 35.62 | 38.49 |
| ROA %i | 8.09 | 8.09 | 10.40 | 13.04 | 13.90 | 14.51 |
| ROIC %i | 9.43 | 9.81 | 13.08 | 17.31 | 18.78 | 20.48 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 18.08 | 18.67 | 21.66 | 23.74 | 25.33 | 26.06 |
| FCF / sales %i | 13.87 | 13.27 | 23.51 | 23.11 | 29.67 | 28.27 |
| Current ratioi | 1.50 | 1.52 | 1.56 | 1.88 | 1.95 | 1.73 |
| Quick ratioi | 1.27 | 1.30 | 1.35 | 1.53 | 1.58 | 1.37 |
| Debt / assetsi | 38.26 | 35.20 | 34.34 | 21.92 | 20.88 | 21.66 |
| LT debt / equityi | 59.79 | 52.46 | 49.34 | 49.82 | 46.14 | 52.56 |
| Interest coveragei | 39.26 | 42.27 | 51.47 | 60.48 | 73.07 | 86.33 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 07:40:14 · For reference only, not investment advice and not tailored to your situation.